Structural insights into the regulatory mechanism of the Pseudomonas aeruginosa YfiBNR system.
10.1007/s13238-016-0264-7
- Author:
Min XU
1
;
Xuan YANG
2
;
Xiu-An YANG
1
;
Lei ZHOU
1
;
Tie-Zheng LIU
1
;
Zusen FAN
3
;
Tao JIANG
4
Author Information
1. National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
2. Chinese Academy of Sciences Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
3. Chinese Academy of Sciences Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. fanz@moon.ibp.ac.cn.
4. National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. tjiang@ibp.ac.cn.
- Publication Type:Journal Article
- Keywords:
L-Trp;
Vitamin B6;
bioflim formation;
c-di-GMP;
peptidoglycan layer;
the YfiBNR system
- MeSH:
Amino Acid Sequence;
Bacterial Proteins;
chemistry;
genetics;
metabolism;
Binding Sites;
Biofilms;
Crystallography, X-Ray;
Cyclic GMP;
analogs & derivatives;
metabolism;
Dimerization;
Molecular Dynamics Simulation;
Molecular Sequence Data;
Mutagenesis;
Protein Structure, Quaternary;
Pseudomonas aeruginosa;
metabolism;
Sequence Alignment;
Tryptophan;
chemistry;
metabolism;
Vitamin B 6;
chemistry;
metabolism
- From:
Protein & Cell
2016;7(6):403-416
- CountryChina
- Language:English
-
Abstract:
YfiBNR is a recently identified bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) signaling system in opportunistic pathogens. It is a key regulator of biofilm formation, which is correlated with prolonged persistence of infection and antibiotic drug resistance. In response to cell stress, YfiB in the outer membrane can sequester the periplasmic protein YfiR, releasing its inhibition of YfiN on the inner membrane and thus provoking the diguanylate cyclase activity of YfiN to induce c-di-GMP production. However, the detailed regulatory mechanism remains elusive. Here, we report the crystal structures of YfiB alone and of an active mutant YfiB(L43P) complexed with YfiR with 2:2 stoichiometry. Structural analyses revealed that in contrast to the compact conformation of the dimeric YfiB alone, YfiB(L43P) adopts a stretched conformation allowing activated YfiB to penetrate the peptidoglycan (PG) layer and access YfiR. YfiB(L43P) shows a more compact PG-binding pocket and much higher PG binding affinity than wild-type YfiB, suggesting a tight correlation between PG binding and YfiB activation. In addition, our crystallographic analyses revealed that YfiR binds Vitamin B6 (VB6) or L-Trp at a YfiB-binding site and that both VB6 and L-Trp are able to reduce YfiB(L43P)-induced biofilm formation. Based on the structural and biochemical data, we propose an updated regulatory model of the YfiBNR system.
